{"ticker": {"uuid": "05ff8d4a-05f2-4a21-9c2f-f7d132822d6d", "symbol": "ENP", "name": "Entropy Neurodynamics Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Entropy Neurodynamics Granted Australian Patent for Psilocin Crystalline Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPZnk0dGtzVUxQNlpidHFHUWhUQUxzMW1FajNLX1BkMGMyOWQ5SmdlQTNPQzI5X1RLek9Jdmc1WXlCT1RaZkxvUWw1WEszRUlTbEZjZWFtUUdXN010QXVVWXBCa3FBem9Vc3V4eXMtZUgzY2R6My1WNlR3dE9JXzJOTlktWlVwRzlNSmw3YTZXQS01b0ZoQ0szNTI4NXp5alJqbnBPTTZnX1FYRG9aaTh2UV9lTVV5T2dkdUc0S0VkejI4Qk9LLUJuRTlsSQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T00:17:15+00:00", "published_display": "10 Jul 2026 00:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Loong Shortz with Entropy Neurodynamics", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-07-09T23:36:00+00:00", "published_display": "09 Jul 2026 23:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Secures Australian Patent for Psilocin Crystalline Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPT0xnQURwdFNOZHA0eFRiMDdEZUh4dEY4Vnk0WWRFUjFMRU1DZndQWGd6cE1HV3Zkd0dwdzd4OW5FeFhna2piaHh3QXBhSWZrSXdFNXpINXkwUEMzMkliY1l0NS1IVTdNaWh3RE1HUW9nTEthVncwZ0dWeTBKUThKOHREdE81TGZjQXluVWpkX3g5bnprZmNZam1TdENPanJkemNMdWVrTl9LTGQtZ19IQkZMZHpkM3FuQVhmQw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-09T23:15:03+00:00", "published_display": "09 Jul 2026 23:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics (ASX:ENP): Could These World-First IV Psilocin Results Be Breakthrough Moment?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOWWZQU2dBOTh1Z05ObzM3cC1vZ1l1TzFIZlgycF9WTk5TWFFrdTdLWi1lM0JKejlBX2RGSkl2SzNHT3VBTjJsMi00ZXNGN0tBN3FkMHpmMXRQT3Q1TUxaQkJzbTRRbUk2aFY4MEw1cW1JQlJiZjBwYmlRZlVQSERaNnVoZnAwendHVlJvR2ZwS3lEWUxjcTk3Y3doS0ZIeFhnZ1M0ZkxQcTZIeGxZeEZjOVh3UEZWbDU3TURsQ1ZJMEt6ZUNJbDBDRUtoVUVWSzg?oc=5", "source_name": "Kalkine", "published_at": "2026-07-07T01:55:00+00:00", "published_display": "07 Jul 2026 01:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Limited (ASX: ENP) Share Price, ENP Stock News, ENP Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9KU24wc0JjQzhBOW91S1lFN2YzNUlBNWhHX21xaTNoSWxZelRwRVAzXzJaQ2hpRnBieHdQMFItX05zT2JkR2pJZE55VXQ1LWtr?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T06:10:00+00:00", "published_display": "02 Jul 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX: ENP \u2014 Entropy Neurodynamics Rides Psychedelic Drug Approval Momentum Into the Spotlight", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOaVVMQkx0LWZtTm1CWG45ZVpoc2FEaGJYVlduYWxITlpYM2k0TEN4NGd2WmhVc0RNbXZuSkQ0azJ4Q2RhN2VlY09FME91bzBnMGxCcVhlQUlYLTI4TVcwX2lwell6Vk9OVUt3MHVBb3RTQUluQm1mTW5pejhxZm9uOGhlRUxfMVRDSHN3b0xDaWlZTF82cVB4X1cxcmF5c2g2VHViMjZYLUgzYVJ0UmVfblNNd09rRGxKM2c5aGJaTVY1RmdITkZSWmF3?oc=5", "source_name": "Kalkine", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biocurious: Entropy rides a supportive wave towards psychedelic drug approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNakJZNGdJdl9HaWVPNlRGVHprWHFaSnlJR0t3RWtyNDNpQXpZU3NJT2FmVEpubGhIWlZ4RzhQZXVPaXZNVEVzZ3UwcXdJZWZwOWl1Z1FNakJrMGZ5Ti1sVDc0b05DVTVkOVUtN1R6TmZrMG1WMDA4OFhFOFM3ODlWdVhNSTliczdNNzNkMTBSaHg2MmtGOU91dUFTRGFyQQ?oc=5", "source_name": "Stockhead", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics (ASX:ENP) Shares Slip Despite DSMB Safety Clearance \u2014 What Do Investors Need to Know?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPRDRVZW0wcXFVZHdvczZRc3gxbnVZb1dvOTFFU2JCWUNPNm9icE5mckUyVGpxX2RweTZyeEY5Y0M4Xy1PUm1yakVIWTdCdW9aN2dlS0Flc2dqT25mQkdfVjR4SWk1VE1wNlh3YV9KZ05scjNSeXcxUVg4dF9hTFhyOS1SLXF6djh0aVdwWTZ3c2N1bllyZlE0Y2NYdFphRzdZbVg3WVlrWFRDajNWU3dyTnBzUUN1NGl0VGVNRnhmbVVKYUJlaDFGUXBoZWI2dG9TSWh0c29rYw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy reports 75pc IBS clinical trial response", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPel9qMHBZMkk4Y1VldWh0enNDOGFvNFB1alZHX0txM1JCbWp3ODRHM2xaZm95QTRQZk14TTNtREtFZ0IwTmVlR3pPSHYtVXA4NXVpRVV6TVJfWi11eXcySmJ4M2phRFAwYklJemZ3MnhHWkFVY29tSUZpS05aZk5RT0lSdHViQ3NQa2xwb0J6U3JhLUJabmJxVXV4eWJaWkNhZkY4dEFCLVAwN3F3NHQ5TnhleXJ2NHJldnJySUlvNlFGcTJvQ2dCTWx1MjJYeTI3YTg4QXo2aEVmQl9KbTl6WnhOUU0tQUZ1UXNZYzlFNVl1bnN6T3RtMtIB_gFBVV95cUxPaEZkU2RITVV0dWIzTE5SN2ZTRldnYy1SSFdYZG1ILTlaRzBYTWMwWlVHakVfUEI4M2hzWEhrMnhPZ19BZDdzVDRYYkw4VGhyWUxQUVpjUTBGX0lqWW1ZTU5WZWVKWXJ6RmdydXJFeDlZaV9vYUY5OFlkWHlrZWhra1RabW5EVTZCbm13REJZWHlkRFBKMFdBdGpxOHhWLUdqUkIxd2NIWlp6Qk5HUy1DRzhHZjVfa3d4NHpUU1pEVFVpZ3Y3QTM0M1dpeUwxX1RpMTFjbWVzVkdvZk44UVRmdllUYkhWQ2NFcEZsOXAtU2M2UW1kcEoxeGJXTnhBdw?oc=5", "source_name": "The Australian", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Prenzler Group initiates coverage on Entropy Neurodynamics", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Granted Australian Patent for TRP8803 to Treat Chronic Pain and Psychiatric Conditions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNbUtTR1ZpdGNRaFpPNEM5OTNJQ1dDdmF0cDBFN241aGlyU016Rnh1cEFVMUpjYmJmOTBWWEhDeGpJTnhvWHpERlhHR0JXMnRxS3dWS2JiMTlUODU0aWc0SHFZTjFXcWN4VXRoY1FrR1ExNGsyWHVsa1d3YmR2czY4V2JlbGhWSjNVOWZSeVRJWk9EYjkyWVktTkM2aUJrZGFpcXJfVmhIUV9tZExKb2lSeFpISlF4ZDEwU3c2YllqWk5fMHl3blRaMVItaGM0NUtqRnpMN2xEY0E?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Entropy Neurodynamics Ltd (ASX:ENP)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE11QXA0aTE2RWZ3MU84bnRpcHdyWE9zS2gtZGNIRDJKU0MyZ3AtdEVGWWptRzdzd0N4dTZ2WE5fOGIzWUhwWlRnUmczbnFjUXR4?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-11-22T05:50:40+00:00", "published_display": "22 Nov 2025 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Limited (ASX: ENP) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQOGFQRm9MMmctUm1BckZ6N0QzdkpGNG1NbWRXMFhPeXRGbnVBanU5d0NDM09PNnhTSTd6dFBXSl9tczZSNFVjTlNEWkZIeXVTazlNbHEtdDhMdWdhbzA1UVh2MlhCZnZWQXo4bFktMG5ybGNqSjJZSzMydFN5TG83UWFFWGNRVHI0ZWktNWlVT3pENEttY09xSWI3Wjl5Zw?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-11-21T14:54:01+00:00", "published_display": "21 Nov 2025 14:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ENP Stock Price and Chart \u2014 ASX:ENP", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1KVFVpSEVLclN3WU82OWJaS2pZYll2QURDSlozZHBwYkItY2tJUlNDbEFiSURKSTh3d19XLUFuRzRBMkljMDFhRFRVTkR2ZjdYWHN3b0lWWQ?oc=5", "source_name": "TradingView", "published_at": "2025-11-21T02:26:09+00:00", "published_display": "21 Nov 2025 02:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Limited (ASX:ENP)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOTjNTZEQ2RXVxZF9PRE40VEdzMmUzNzVfTXBGNkN5M2k0STJHdzVxLVFra21IYldKQ3VsWGRhRW05T012TFlrc2RzYzhObUlTbHB1dHBVTmRVYWFvVXhLN1V2alVBRXBmUDJfTVo3UFRETEFRWmo5b0RzWnhZS1hTQWtuYXN2NllydW44?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-11-20T17:24:17+00:00", "published_display": "20 Nov 2025 17:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Entropy Neurodynamics Granted Australian Patent for Psilocin Crystalline Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPZnk0dGtzVUxQNlpidHFHUWhUQUxzMW1FajNLX1BkMGMyOWQ5SmdlQTNPQzI5X1RLek9Jdmc1WXlCT1RaZkxvUWw1WEszRUlTbEZjZWFtUUdXN010QXVVWXBCa3FBem9Vc3V4eXMtZUgzY2R6My1WNlR3dE9JXzJOTlktWlVwRzlNSmw3YTZXQS01b0ZoQ0szNTI4NXp5alJqbnBPTTZnX1FYRG9aaTh2UV9lTVV5T2dkdUc0S0VkejI4Qk9LLUJuRTlsSQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T00:17:15+00:00", "published_display": "10 Jul 2026 00:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Loong Shortz with Entropy Neurodynamics", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-07-09T23:36:00+00:00", "published_display": "09 Jul 2026 23:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Secures Australian Patent for Psilocin Crystalline Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPT0xnQURwdFNOZHA0eFRiMDdEZUh4dEY4Vnk0WWRFUjFMRU1DZndQWGd6cE1HV3Zkd0dwdzd4OW5FeFhna2piaHh3QXBhSWZrSXdFNXpINXkwUEMzMkliY1l0NS1IVTdNaWh3RE1HUW9nTEthVncwZ0dWeTBKUThKOHREdE81TGZjQXluVWpkX3g5bnprZmNZam1TdENPanJkemNMdWVrTl9LTGQtZ19IQkZMZHpkM3FuQVhmQw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-09T23:15:03+00:00", "published_display": "09 Jul 2026 23:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics (ASX:ENP): Could These World-First IV Psilocin Results Be Breakthrough Moment?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOWWZQU2dBOTh1Z05ObzM3cC1vZ1l1TzFIZlgycF9WTk5TWFFrdTdLWi1lM0JKejlBX2RGSkl2SzNHT3VBTjJsMi00ZXNGN0tBN3FkMHpmMXRQT3Q1TUxaQkJzbTRRbUk2aFY4MEw1cW1JQlJiZjBwYmlRZlVQSERaNnVoZnAwendHVlJvR2ZwS3lEWUxjcTk3Y3doS0ZIeFhnZ1M0ZkxQcTZIeGxZeEZjOVh3UEZWbDU3TURsQ1ZJMEt6ZUNJbDBDRUtoVUVWSzg?oc=5", "source_name": "Kalkine", "published_at": "2026-07-07T01:55:00+00:00", "published_display": "07 Jul 2026 01:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Limited (ASX: ENP) Share Price, ENP Stock News, ENP Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9KU24wc0JjQzhBOW91S1lFN2YzNUlBNWhHX21xaTNoSWxZelRwRVAzXzJaQ2hpRnBieHdQMFItX05zT2JkR2pJZE55VXQ1LWtr?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T06:10:00+00:00", "published_display": "02 Jul 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX: ENP \u2014 Entropy Neurodynamics Rides Psychedelic Drug Approval Momentum Into the Spotlight", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOaVVMQkx0LWZtTm1CWG45ZVpoc2FEaGJYVlduYWxITlpYM2k0TEN4NGd2WmhVc0RNbXZuSkQ0azJ4Q2RhN2VlY09FME91bzBnMGxCcVhlQUlYLTI4TVcwX2lwell6Vk9OVUt3MHVBb3RTQUluQm1mTW5pejhxZm9uOGhlRUxfMVRDSHN3b0xDaWlZTF82cVB4X1cxcmF5c2g2VHViMjZYLUgzYVJ0UmVfblNNd09rRGxKM2c5aGJaTVY1RmdITkZSWmF3?oc=5", "source_name": "Kalkine", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biocurious: Entropy rides a supportive wave towards psychedelic drug approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNakJZNGdJdl9HaWVPNlRGVHprWHFaSnlJR0t3RWtyNDNpQXpZU3NJT2FmVEpubGhIWlZ4RzhQZXVPaXZNVEVzZ3UwcXdJZWZwOWl1Z1FNakJrMGZ5Ti1sVDc0b05DVTVkOVUtN1R6TmZrMG1WMDA4OFhFOFM3ODlWdVhNSTliczdNNzNkMTBSaHg2MmtGOU91dUFTRGFyQQ?oc=5", "source_name": "Stockhead", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics (ASX:ENP) Shares Slip Despite DSMB Safety Clearance \u2014 What Do Investors Need to Know?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPRDRVZW0wcXFVZHdvczZRc3gxbnVZb1dvOTFFU2JCWUNPNm9icE5mckUyVGpxX2RweTZyeEY5Y0M4Xy1PUm1yakVIWTdCdW9aN2dlS0Flc2dqT25mQkdfVjR4SWk1VE1wNlh3YV9KZ05scjNSeXcxUVg4dF9hTFhyOS1SLXF6djh0aVdwWTZ3c2N1bllyZlE0Y2NYdFphRzdZbVg3WVlrWFRDajNWU3dyTnBzUUN1NGl0VGVNRnhmbVVKYUJlaDFGUXBoZWI2dG9TSWh0c29rYw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy reports 75pc IBS clinical trial response", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPel9qMHBZMkk4Y1VldWh0enNDOGFvNFB1alZHX0txM1JCbWp3ODRHM2xaZm95QTRQZk14TTNtREtFZ0IwTmVlR3pPSHYtVXA4NXVpRVV6TVJfWi11eXcySmJ4M2phRFAwYklJemZ3MnhHWkFVY29tSUZpS05aZk5RT0lSdHViQ3NQa2xwb0J6U3JhLUJabmJxVXV4eWJaWkNhZkY4dEFCLVAwN3F3NHQ5TnhleXJ2NHJldnJySUlvNlFGcTJvQ2dCTWx1MjJYeTI3YTg4QXo2aEVmQl9KbTl6WnhOUU0tQUZ1UXNZYzlFNVl1bnN6T3RtMtIB_gFBVV95cUxPaEZkU2RITVV0dWIzTE5SN2ZTRldnYy1SSFdYZG1ILTlaRzBYTWMwWlVHakVfUEI4M2hzWEhrMnhPZ19BZDdzVDRYYkw4VGhyWUxQUVpjUTBGX0lqWW1ZTU5WZWVKWXJ6RmdydXJFeDlZaV9vYUY5OFlkWHlrZWhra1RabW5EVTZCbm13REJZWHlkRFBKMFdBdGpxOHhWLUdqUkIxd2NIWlp6Qk5HUy1DRzhHZjVfa3d4NHpUU1pEVFVpZ3Y3QTM0M1dpeUwxX1RpMTFjbWVzVkdvZk44UVRmdllUYkhWQ2NFcEZsOXAtU2M2UW1kcEoxeGJXTnhBdw?oc=5", "source_name": "The Australian", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Prenzler Group initiates coverage on Entropy Neurodynamics", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Granted Australian Patent for TRP8803 to Treat Chronic Pain and Psychiatric Conditions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNbUtTR1ZpdGNRaFpPNEM5OTNJQ1dDdmF0cDBFN241aGlyU016Rnh1cEFVMUpjYmJmOTBWWEhDeGpJTnhvWHpERlhHR0JXMnRxS3dWS2JiMTlUODU0aWc0SHFZTjFXcWN4VXRoY1FrR1ExNGsyWHVsa1d3YmR2czY4V2JlbGhWSjNVOWZSeVRJWk9EYjkyWVktTkM2aUJrZGFpcXJfVmhIUV9tZExKb2lSeFpISlF4ZDEwU3c2YllqWk5fMHl3blRaMVItaGM0NUtqRnpMN2xEY0E?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Entropy Neurodynamics Ltd (ASX:ENP)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE11QXA0aTE2RWZ3MU84bnRpcHdyWE9zS2gtZGNIRDJKU0MyZ3AtdEVGWWptRzdzd0N4dTZ2WE5fOGIzWUhwWlRnUmczbnFjUXR4?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-11-22T05:50:40+00:00", "published_display": "22 Nov 2025 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Limited (ASX: ENP) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQOGFQRm9MMmctUm1BckZ6N0QzdkpGNG1NbWRXMFhPeXRGbnVBanU5d0NDM09PNnhTSTd6dFBXSl9tczZSNFVjTlNEWkZIeXVTazlNbHEtdDhMdWdhbzA1UVh2MlhCZnZWQXo4bFktMG5ybGNqSjJZSzMydFN5TG83UWFFWGNRVHI0ZWktNWlVT3pENEttY09xSWI3Wjl5Zw?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-11-21T14:54:01+00:00", "published_display": "21 Nov 2025 14:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ENP Stock Price and Chart \u2014 ASX:ENP", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1KVFVpSEVLclN3WU82OWJaS2pZYll2QURDSlozZHBwYkItY2tJUlNDbEFiSURKSTh3d19XLUFuRzRBMkljMDFhRFRVTkR2ZjdYWHN3b0lWWQ?oc=5", "source_name": "TradingView", "published_at": "2025-11-21T02:26:09+00:00", "published_display": "21 Nov 2025 02:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Entropy Neurodynamics Limited (ASX:ENP)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOTjNTZEQ2RXVxZF9PRE40VEdzMmUzNzVfTXBGNkN5M2k0STJHdzVxLVFra21IYldKQ3VsWGRhRW05T012TFlrc2RzYzhObUlTbHB1dHBVTmRVYWFvVXhLN1V2alVBRXBmUDJfTVo3UFRETEFRWmo5b0RzWnhZS1hTQWtuYXN2NllydW44?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-11-20T17:24:17+00:00", "published_display": "20 Nov 2025 17:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 15, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 15, "score": 50, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.04, "latest_week": "2026-07-10", "one_week_move": 9.4, "four_week_move": 12.9, "twelve_week_move": 25.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.057723, "market_dynamics_buy_signal": false, "relative_strength": 2.762284, "fair_value_gap": 30.7, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 37.9464, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+9.4% over one week, +12.9% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 5}, {"label": "The Australian", "count": 3}, {"label": "smallcaps.com.au", "count": 2}, {"label": "intelligentinvestor.com.au", "count": 2}, {"label": "marketscreener.com", "count": 1}, {"label": "Stockhead", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Regulatory and legal", "count": 2}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+9.4% over one week, +12.9% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Entropy Neurodynamics Granted Australian Patent for Psilocin Crystalline Forms"}], "updated_at": "2026-07-17T15:33:41.587500+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}